2mg / vial HGH Human Growth Hormone Peptide CJC 1295 Without Dac CAS 863288-34-0

2mg / vial HGH Human Growth Hormone Peptide CJC 1295 Without Dac CAS 863288-34-0

Quick detail :

• Product name : CJC 1295 ; CJC 1295 without DAC
• Alias: CJC-1295 Acetate; CJC1295(Without DAC)
• CAS No.: 863288-34-0
• Molecular Formula: C165H271N47O46
• Molecular Weight: 3649.30
• Purity (HPLC): 98.0%
• Appearance: White powder
• Manufacurer: Quanao
• Single Impurity(HPLC): 1.0%
• Amino Acid Composition: 10% of theoretical
• Peptide Content(N%): 80%(by %N)
• Water Content(Karl Fischer): 6.0%
• Acetate Content(HPIC): 15.0%
• MS(ESI): N/A
• Mass Balance: 95.0~105.0%

CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural

CJC-1295 NO-DAC(MOD GRF 1-29) description:
CJC-1295 is a Long acting GHRH analog.hormone-releasing hormone (GHRH), also known as hormone-releasing factor (GRF or GHRF) or somatocrinin, is a 44-amino acid peptide hormone produced in the hypothalamus by the arcuate nucleus. GHRH stimulates hormone (GH) secretion from the pituitary. GHRH is released in a pulsatile manner, stimulating pulsatile release of GH respectively.

Product Description:
Introduction:CJC-1295 is a synthetic GHRH analog that selectively and covalently binds to endogenous albumin after injection, thereby extending its half-life and duration of action. Subcutaneous administration of CJC-1295 resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated, particularly at doses of 30 or 60 microg / kg. There was evidence of a cumulative effect after multiple doses. These data support the potential utility of CJC-1295 as a therapeutic agent.

Whats the difference between CJC-1293 (MOD GRF 1-29) and CJC 1295 ?
CJC-1293 or modified GRF(1-29) is a synthetic modification of growth hormone releasing factor (GRF) with D-Ala, Gln, Ala, and Leu substitutions at positions 2,8,15,and 27 respectively. These substitutions create a much more stable peptide with the substitution at position 2 to prevent DPP-IV cleavage, at position 8 to reduce asparagine rearrangement or amdie hydrolysis to aspartic acid, position 15 to enhance bio-activity, and position 27 to prevent methionine oxidation.
CJC1293 is a short acting secretogoge, It is often falsley sold as CJC 1295. Unless you have a good source and buy CJC 1295 you are most likely getting CJC1293 which is the reason many people dose their CJC1295 daily just to be safe. because it is easier to make and is cheaper. has to be injected daily.

Specification:

Packaging & Delivery Process:

1. Delivery Guarantee
   There are many kinds of express way to choose .We had 15 years of experience in this field .
2. Package
   Peptides and steroids would be packaged discreetly , it is enough to pass customs .

3. After-sales service                                                                                              We will offer you package photos after your payment , so that you can distinguish between products.